Imagion Nanoparticle Manufacturing Update

Imagion Nanoparticle Manufacturing Update

Imagion Biosystems Limited is pleased to report that the first phase of manufacturing of the MagSense® HER2 nanoparticle formulation under Good Manufacturing Practice (GMP) conditions has proceeded uninterrupted by the pandemic and has been completed on time. The second phase of manufacturing the nanoparticle material is expected to continue on schedule as the Company makes ready for its first human study.

Read Imagion Nanoparticle Manufacturing Update.

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.